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Melanocortin 1 receptor biology and skin
Healy E. School of Medicine, Southampton General Hospital, England, UK
The melanocortin 1 receptor (MC1R, Mc1r) gene encodes for a seven pass transmembrane G-
protein coupled receptor which is expressed on melanocytes and melanoma cells. Alterations in
this gene are associated with distinct coat colours throughout the animal kingdom as a result of
the mutation enhancing receptor binding and/or function or resulting in loss of receptor activity.
The human MC1R gene is highly polymorphic, with over 35 coding region variants identified to
date. Many of these variants, especially the Arg151Cys, Arg160Trp and Asp294His changes, are
seen at a high frequency in individuals with red hair and fair skin type. Although these variant
receptors bind ligand with similar affinity to the wild type receptor, signalling via intracellular
cyclicAMP is compromised, thereby leading to the preferential production of a lighter
phaeomelanic phenotype. Subjects with MC1R variants are at increased risk of developing
melanoma and non-melanoma skin cancer, and part of the higher risk is due to the altered
pigmentation. However, evidence is accumulating from several investigational approaches to
indicate that a significant part of the elevated risk of skin cancer development in individuals with
MC1R variants is due to effects on non-pigmentary pathways, some of which are independent of
the cyclicAMP signalling cascade.
New aspects in the pathophysiology and treatment of pemphigus
Kristian Reich, MD, Professor of Dermatology Dermatologikum Hamburg
Pemphigus is a severe autoimmune condition characterized by the presence of autoantibodies
against components of the desmosomal connection between keratinocytes. Three main subtypes,
pemphigus vulgaris (PV), foliaceus and paraneoplastic pemphigus, can be distinguished based on
clinical, histological and immunofluorescence microscopic findings as well as differences in the
autoantigen spectrum. The crucial role of anti-desmoglein autoantibodies in the pathophysiology
of pemphigus has been demonstrated in passive transfer models, where newborn mice developed
typical blisters and erosions after the injection of serum from affected patients. More recent
studies, mainly in PV, have highlighted the role of autoreactive T cells. Desmoglein-specific Th1-
and Th2-like T cells have been identified that are activated in the context of PV-associated HLA-
DR and –DQ molecules and are likely to contribute to the production of IgG1 and IgG4 anti-
desmoglein antibodies, respectively. These autoreactive T cells are present not only in affected
patients, but also in healthy carriers of the PV-associated HLA class II molecules. There is also
evidence to suggest that in vivo the effects of these autoreactive T cells on the production of
autoantibodies and the manifestation of PV are counterbalanced by regulatory T cells (Treg).
Desmoglein-reactive Tregs phenotypically and functionally resembling type 1 Tregs (Tr1) were
found in the majority of healthy carriers of PV-associated MHC class II alleles but in less than 20%
of the investigated PV patients. When the expression of Foxp3, a gene activated in Tr1 cells that
encodes a transcription repressor critical for Treg development, is inhibited by antisense
strategies, desmoglein-reactive Tr1 cells shift toward the dangerous Th2 phenotype and loose
their suppressive capacity. These novel findings support a model of pemphigus pathophysiology,
in which the ratio of desmoglein-reactive Tr1 to Th2 cells in carriers of PV-associated HLA class II
molecules is critical for the maintenance of tolerance at the B cell level and the prevention of the
PV phenotype. Recent advances in the treatment of pemphigus, including immunoadsorption (IA)
for the fast removal of autoantibodies, and rituximab, a chimeric antibody that depletes CD20þ B
cells (but not plasma cells), are likely to act primarily through inhibition of humoral
autoimmunity, although rituximab may also influence autoreactive T cells secondary to effects
on autoantigen presentation by B cells. From the limited experience so far available (on last count
24 published pemphigus patients received rituximab), it seems that IA is able to induce at least
partial remission in the majority of patients within weeks, but is less effective in the maintenance
of clinical responses. The maximum response to rituximab may take several months but complete
remissions may be achieved in up to 30% of cases. A strategy using IA in combination with
rituximab may be favourable in severe cases. These therapies are usually combined with classical
corticosteroid/azathioprin regimes which are tapered according to individual responses.
The author is indebted to Professor M Hertl, Marburg, and Professor D Zillikens, Lu¨beck, for
sharing scientific and clinical data on the topic.
[Nle4-D-Phe7]-a-Melanocyte stimulating hormone, significantly increased pig-
mentation and decreased UV damage in fair-skinned Caucasian volunteers
Ross StC. Barnetson1, Terry K.T. Ooi1, Liqing Zhuang1, Gary M. Halliday1, Catherine M. Reid2,
Patrick C. Walker2 and Stuart M. Humphrey3
1Department of Dermatology, Royal Prince Alfred Hospital at the University of Sydney, Sydney,
Australia; 2Royal Adelaide Hospital, Adelaide, Australia; and 3Epitan Ltd, Melbourne, Australia
Epidermal melanin can reduce some of the effects of ultraviolet radiation, which is the major
cause of skin cancer. To examine whether induced-melanin can provide protection from sunburn
injury, 79 subjects were recruited into a clinical trial with the potent synthetic melanotropin,
Melanotan, delivered by subcutaneous injection into the abdomen at 0.16 mg/kg for three 10 day
cycles over 3 months. Sixty five subjects completed and, compared with placebo, the skin
Melanin Density, measured by reflectance spectroscopy, increased significantly in all Melanotan-
treated subjects. The highest increases were seen in those volunteers with the lowest baseline skin
melanin levels. In subjects with a skin type associated with a low MED at baseline, melanin
increased by an average of 41% (from 2.55 to 3.59, Po0.0001 versus placebo) over eight
separate skin sites compared with only 12% (from 4.18 to 4.70, Po0.0001 versus placebo) in
subjects with a high MED skin type. Epidermal sunburn (apoptotic) cells resulting from exposure
to 3 an individual’s MED exposure of solar-simulated ultraviolet radiation were reduced by
more than 50% after Melanotan treatment in the volunteers with low baseline MED. DNA
damage, in the form of thymine dimer formation, was also shown to be reduced by 59%
(P¼ 0.0033) in the basal layer of the epidermis of this group of subjects. This study has shown for
the first time the potential ability of a synthetic hormone, that augments melanin production, to
provide photoprotection to people who normally burn in direct sunlight.
Female pattern hair loss, dandruff and greying of hair in twins
Rodney Sinclair, Julia Huyn, Sylvia van Egmond, Carlijn Hoedemaker, Adam Chapman*
University of Melbourne, Department of Medicine and School of Health Sciences, Deakin
University, Melbourne, Australia
Background: Twin studies have demonstrated male pattern hair loss (MPHL) has a hereditability
of around 80%, indicating that around 80% of the total variance in MPHL could be attributed to
additive genetic effects. The heritability of female pattern hair loss (FPHL) is not known, nor is the
heritability of dandruff or greying of hair. MPHL is associated with increased risk of prostate
cancer. Cancer risk in association with FPHL has not been investigated.
Objectives: To investigate the heritability of FPHL through twin concordance. Secondary aims are
to investigate the hereditability of dandruff and grey hair and to assess how differences in hair
thickness relate to dandruff, grey hair and certain types of cancer.
Methods: A pilot study was conducted among 100 twin pairs. All completed questionaires prior to
attending scalp examination. Subsequently questionnaires were mailed to 1000 female twin pairs
(2000 females), aged between 21 and 75. Twins recorded their own hair thickness and that of
their sister as well as presence or history of dandruff, grey hair and cancer.
Results: 412 (¼ 824 QN) questionnaires (response rate 41.2%) were returned, of which 249 were
monozygotic (N¼ 498) and 163 were dizygotic (N¼ 326) twin pairs. Heritability for FPHL in the
pilot study was 0.75. In the main study hereditability wasB0.69 in self-scored hair thickness and
B0.86 in twin rating hair-thickness. Hair greying and dandruff showed less strong heritability
with scores of 0.3 and 0.4 respectively. All heritability outcomes are significantly greater than 0,
with an intraclass correlation that is greater in MZ twins than in DZ twins.
Conclusion: There is a strong heritability for female pattern hair loss, under both conditions of
self-rating of hair thickness, and twin rating of hair thickness. Additive genetic effects play a major
role in the development of FPHL. The development of dandruff and grey hair are also hereditable,
but appear more dependant on non-shared environmental effects.
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Heterozygous carriers of an intragenic deletion in the gene encoding collagen
XVII, COL17A1: 823delA, exhibit dental abnormalities in a family with non-
herlitz junctional epidermolysis bullosa
AMG Pasmooij1, MF Jonkman1, HH Pas1, S Klingberg2, E Pfendner3, J Uitto3, F Collins4, R P
Widmer5 DF Murrell6,7
1University Medical Centre, Groningen, Netherlands; 2Royal Brisbane Hospital; 3Thomas
Jefferson University, Philadelphia; 4Westmead Hospital Genetics Dept, Sydney; 5Children’s
Hospital at Westmead, Dental Dept, Sydney; 6St George Hospital, Sydney and 7University of
New South Wales, Sydney
Background: Two children born to a consanguineous Iraqi couple developed blistering from birth.
The first had died at age 9 months and the second after 4 weeks. Both had widespread erosions
but no hoarse cry. The parents and an older son were phenotypically normal except that they all
had pitting of their teeth. The father and mother had some vertical ridging and pigmentation of
their 5th toenails. The type of EB was not known.
Methods: Skin biopsies of rubbed areas of skin from the parents were processed for IF mapping
and electron microscopy. The LAMB3, C2, A3 and COL17A1 genes were screened for mutations.
Keratinocytes were cultured from a skin biopsy for COL17A1 mRNA expression studies and
immunoblotting of collagen XVII. Prenatal diagnosis was performed from CVS tissue at 10 weeks’
gestation.
Results: IF mapping identified reduced expression of type XVII collagen (1D1). Mutation analysis
of COL17A1 identified the heterozygous presence of a novel COL17A1 mutation 823delA in both
parents and the brother. This mutation causes a frameshift and leads to a premature termination
codon downstream. Digenic mutations in other genes involved in JEB were excluded by screening
of the LAMA3, LAMB3 and LAMC2 genes. RT-PCR of cultured keratinocytes showed no aberrant
mRNA transcripts of the mutated allele. Immunoblot revealed only the wildtype type XVII
collagen band. The fetus was a carrier of the COL17A1 mutation and a normal baby was born.
The primary teeth have not yet erupted.
Conclusions: Heterozygous carriers of COL17A1 mutations usually show a normal skin
phenotype and have no teeth problems, although in a few cases minor dental problems have
been reported due to missense mutations (G609D, G612R, G627V, & G633D) and in one
instance a PTC mutation, R1226X, in carriers. This study provides further evidence that not only
carriers of heterozygous COL17A1 missense mutations may display dental abnormalities as a
mini-symptom, but they are also carriers of an intragenic COL17A1 deletion.
CRE/LOXP-Mediated inactivation of vascular endothelial growth factor in
keratinocytes sensitizes mouse skin to UVB-induced photo-damage
Heidemarie Rossiter1, Caterina Barresi1, Minoo Ghanaddan1, Florian Gruber1, Erwin F. Wagner2
and Erwin Tschachler1,3
1Department of Dermatology, Medical University of Vienna, Vienna, Austria; 2Research Institute
for Molecular Pathology, Vienna, Austria and 3CE.R.I.E.S, Neuilly, France
Background: Acute and chronic sun exposure results in sunburn and skin photoaging
respectively. Both feature prominent changes in the skin microvasculature, namely vascular
hyperpermeability and erythema in the former, and a rarefaction of subepidermal capillaries in
the latter. Vascular Endothelial Growth Factor (VEGF) is one of several pro-angiogenic cytokines
that are induced in epidermal keratinocytes (KC) after UVB irradiation.
Methods: Mice in which the VEGF gene was specifically inactivated in KC by means of the cre/
loxP system, together with controls, were irradiated on their shaved backs either once with
500 mJ/cm2 UVB (acute), or for 10 weeks with a cumulative dose of 6,7 J/cm2 (chronic).
Angiogenesis and VEGF production in irradiated skin were examined by histology and ELISA
respectively at various times thereafter.
Results: Mutant unirradiated skin harbored significantly less VEGF than that of controls. The
mutants, but not controls, developed necrotic skin wounds after acute high dose irradiation, and
failed to upregulate VEGF protein in the epidermis. In vitro, mutant KC were not per se more
sensitive to UVB, but irradiated mutant skin showed strongly enhanced TUNEL positivity (a
measure of cell death) of vascular endothelial cells (EC), less EC proliferation and a significant
reduction of subepidermal capillaries compared to irradiated control skin. Chronic low dose
irradiation did not induce wounds in either group, but control mice had increased blood vessel
densities, while the mutants showed levels below those of unirradiated animals, reminiscent of
aspects of photoaged skin.
Conclusion: Our results demonstrate that keratinocyte-derived VEGF is important for preventing
UVB-induced skin damage by promoting EC survival and proliferation.
Isolation and identification of breast stem cells
Jane E. Visvader The Walter and Eliza Hall Institute of Medical Research, 1G Royal Parade,
Parkville, Victoria 3050, Bone Marrow Research Laboratories, Royal Melbourne Hospital,
Parkville, Victoria 3050
The existence of mammary stem cells (MaSCs) has been postulated from evidence that the
mammary gland can be regenerated by transplantation of epithelial fragments in mice. Interest in
MaSCs has been further stimulated by their potential role in breast tumorigenesis4. However, the
identity and purification of MaSCs has proved elusive owing to the lack of defined markers. We
isolated discrete populations of mouse mammary cells on the basis of cell-surface markers and
identified a subpopulation (Lin2CD29hiCD241) that is highly enriched for MaSCs by
transplantation. Here we show that a single cell, marked with a LacZ transgene, can reconstitute
a complete mammary gland in vivo. The transplanted cell contributed to both the luminal and
myoepithelial lineages and generated functional lobuloalveolar units during pregnancy. The self-
renewing capacity of these cells was demonstrated by serial transplantation of clonal outgrowths.
In support of a potential role for MaSCs in breast cancer, the stem cell-enriched subpopulation
was expanded in premalignant mammary tissue from MMTV-wnt-1 mice and contained a higher
number of MaSCs. Our data establish that single cells within the Lin2CD29hiCD241 population
are multipotent and self renewing, properties that define them as MaSCs.
Adipogenesis
Morrison W, Thompson R, Thomas G, Abbiton K Bernard O’Brien Institute of Microsurgery, St
Vincent’s Hospital, Melbourne
Adipogenesis or fat production is of interest to plastic surgeons to recreate large defects following
incidents such as mastectomy or congenital deformities involving soft tissue defects and for
smaller problems as in cosmetic surgery. There are broader issues relating to adipogenesis such as
obesity, atherosclerosis and metabolic syndrome.
Our initial interest in adipogenesis stemmed from animal models of tissue engineering where we
grew granulation tissue from implanted vascular pedicles. When we added muscle tissue to the
chambers in rats, fat spontaneously grew. When we repeated this into a mouse model and
inserted fat or muscle new fat also formed. Further manipulation of the mouse model using human
fat showed that it was not survival of the graft cells and there subsequent expansion, but systemic
signalling to the animal to produce its own endogenous fat. We believe that this is an
inflammatory signal as it can be mimicked by zymosal and we are currently investigating the
chemokine, cytokine and cellular responses involved. This not only has applications for tissue
engineering but may give new insights into obesity and other disorders.
In another model where we inserted a living flap of fat into a large empty chamber, new fat grew
to fill the space. The mechanism of this growth is a local proliferation stimulus to primitive cell
populations probably related to mechanotransduction forces and these can be enhanced by
traction forces applied across the chamber.
These models allow us to investigate the invo sequence of cellular and chemical responses
involved in the proliferation and differentiation involved in fat production.
www.jidonline.org 2681
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There’s a fly in the wound
Jane SM, Ting SB, Caddy J, Hislop N, Wilanowski T, Auden A, Zhao L-L, Ellis S, Kaur P, Uchida Y,
Elias PM, Holleran WM, Cunningham JM
Rotary Bone Marrow Research Laboratories, C/- Royal Melbourne Hospital Post Office, Grattan
Street, Parkville, Victoria, Australia, 3050; Microscopy Imaging Facility and 3Epithelial Stem Cell
Biology Laboratory, Peter MacCallum Research Institute, East Melbourne, Victoria, Australia;
Dermatology Service and Research Unit, Department of Veteran Affairs Medical Center and
Department of Dermatology, School of Medicine, University of California, San Francisco, USA;
Division of Experimental Haematology, St Jude Children’s Research Hospital, Memphis,
Tennessee, USA
During Drosophila development, the epidermal epithelium deposits the embryonic cuticle, a
tough waterproof layer essential for maintaining the barrier defences of the organism. Integral to
cuticle resilience is the transcription factor, grainyhead, which regulates production of Dopa
decarboxylase, the enzyme required for covalent cross-linking of the cuticular structural
components. We now report that formation and maintenance of the impermeable epidermal
barrier in mice is dependent on a mammalian homologue of grainyhead, Grainyhead-like 3. Mice
lacking this factor display defective skin barrier function an deficient embryonic and adult wound
repair. These defects are accompanied by reduced expression of transglutaminase 1, the key
enzyme involved in cross-linking the structural components of the superficial layer of the
mammalian epidermis. These findings suggest that the functional mechanisms involving protein
cross-linking that maintain the epidermal barrier and induce tissue repair are conserved across
700 million years of evolution.
Glutathione peroxidase deficiency contributes to UV-induced SCC formation:
implications for prophylactic treatments for cutaneous SCC
Saunders N, Walshe J1, Serewko-Auret M1, Chu FF2, Esworthy S2, Cameron S1, Teakle N1,
Reeve V3
1Centre for Immunology & Cancer Research, University of Queensland; 2City of Hope Medical
Center, Duarte, CA, USA and 3Department of Veterinary Sciences, University of Sydney
Background: The glutathione peroxidases are a family of enzymes involved in the biotransforma-
tion of organic and inorganic peroxides. Peroxides are frequently classified as reactive oxygen
species (ROS). Since ROS have been causally implicated in various pathological conditions such
as cancer, we have examined the rule that GPX activity may play in the development of CSCC.
Methods: Culture and isolation of human epidermal keratinocytes and the culture of SCC cell
linex has been described (1). Samples of resected SCC were obtained with ethical approval. Cell
and tissue extracts were subjected to a number of assays to examine (1) gpx isoform mRNA or
protein expressions, (2) gpx activity and (3) peroxide levels. In addition, gpx-1 or gpx-2 KO mice
(2) were used in protocols to examine their sensitivity to UV-induced SCC formation using
established techniques (3,4).
Results: Our studies have demonstrated the following:
(1) gpx activity is significantly reduced in SCC cell lines and patient SCC
(2) reduction in gpx activity is not associated with decreased protein expression
(3) gpx deficiency is associated with an increased peroxidative burden
(4) gpx activity is directly regulated by intracellular peroxide burden
(5) gpx-deficiency predisposes mice to UV-induced SCC
Conclusion: These data indicate that gpx deficiency is likely to be a key event in SCC formation.
In addition, these data indicate that gpx inactivation is via a post-translational mechanism. These
data also raise the exciting possibility that peroxide modulating drugs may be valuable agents to
prevent CSCC. This may be of particular value in the immuno-suppressed patient.
References
(1) Wong CF, Barnes LM, Dahler AL, Smith L, Serewko-Auret MM, Popa C, Jappar IA, Saunders
A J Biol Chem, 278(31): 28516-22 2003
(2) Chu FF, Esworthy RS, Chu PC, Longmate JA, Huycke MM, Wilczynski S, Doroshow JH.
Cancer Res, 64:962-8 2004
(3) Allanson M, Reeve VE. J Invest Dermatol 122:1030-6 2004
(4) Reeve VE, Domanski D. Photochem. Photobiol 76:401-5 2002
Effects of E2F-1 over-expression upon proliferation and DNA repair in UVA-
irradiated SCC9 cell lines1
Rhonda A. Kwong1,2,3, Toby H.Corlette3, Elizabeth A. Musgrove3, Robert L. Sutherland3, Ross S.
Barnetson1,2 and Gary M. Halliday1
1Dermatology Research Laboratories, Blackburn Building, University of Sydney, NSW [R.A.K.,
R.S.B. and G.M.H.]; 2Department of Dermatology, Royal Prince Alfred Hospital, Camperdown,
NSW [R.A.K. and R.S.B.] and3Cancer Research Program, Garvan Institute of Medical Research
[R.A.K., T.H.C., E.A.M. and R.L.S.,], Darlinghurst, N.S.W. 2010 Australia
Introduction: E2F-1 is commonly over-expressed in squamous cell carcinomas (SCC) and has
opposing roles in cancer development. E2F-1 function is tissue specific and can vary from
promoting proliferation and S phase entry, enhancing DNA repair or initiating apoptosis. The
effects of E2F-1 over-expression in SCC after UVA-irradiation remains to be elucidated.
Method: Effects of UVA irradiation (fromB2200 mJ/cm2 toB26 000 mJ/cm2) of SCC9 parent cell
lines and stably transfected clones E2F-1 over-expressing clones were compared controls in vitro
with respect to proliferation, colony forming ability, apoptosis and DNA repair.
Results: UVA-irradiated parent SCC9 cells demonstrated a greater dose-dependant reduction in
proliferation rates and colony forming ability compared to E2F-1 over-expressing clones which
remained largely resistant. E2F-1 over-expressing clones demonstrated enhanced DNA repair at
low dose (2200 mJ/cm2) and early high dose (26 000 mJ/cm2) UVA-irradiation. Parent SCC9 cell
lines demonstrated a G1 arrest coinciding with an increased p27
WAF1:E2F-1 protein expression
ratio 24 hours after UVA-irradiation which was not demonstrated in E2F-1 over-expressing clones.
Moreover, enhanced DNA repair ability of E2F-1 over-expressing clones after UVA-irradiation
appeared to be negated by loss of G 1/S phase checkpoint regulation 24 hours after high dose
UVA-irradiation.
Conclusions: These data suggest that deregulated E2F-1 over-expression promoted oncogenesis
though increased proliferation and clonogenic potential through an inability to up-regulate
p27WAF1 and despite enhancing DNA repair. Manipulation of E2F-1 expression may have
therapeutic utility in patients with SCC which over-express E2F-1.
Radiation sources providing increasing UVA/UVB ratios result in increasing UVA
dose-dependent photoprotection in mice
V.E. Reeve1, D. Domanski1 and M. Slater1
1Faculty of Veterinary Science, 1Department of Anatomy, University of Sydney
Background: In studies in mice in which UVA (320–400 nm) and UVB (290–320 nm) radiation
were administered alone or combined but sequentially, we have reported a protective action by
UVA against UVB-induced erythema/oedema and systemic suppression of contact hypersensi-
tivity. The UVA immunoprotection was found to operate within a defined window of UVA doses
that fell within environmentally attainable exposures. Mechanistically, the UVA effect was shown
to be mediated by the induction of the stress enzyme heme oxygenase-1 (HO-1) in the skin, of
which the enzymatic product, gaseous carbon monoxide, was shown to be responsible, and to act
via the activation of the cyclic guanosine monophosphate pathway in the skin. The UVA
immunoprotected state was associated with the protection of the cutaneous Th-1 cytokines IFN-g
and IL-12 from UVB-induced depletion, and the inhibition of the UVB-induced expression of the
Th-2 cytokine IL-10.
Methods: We have now sought evidence for such an immunological waveband interaction when
UVA and UVB are administered concurrently to hairless mice, as occurs in sunlight exposure in
humans. A series of spectra providing varying ratios of UVA/UVB were developed, with the UVA
ratio enhanced up to approximately 3.5 times the UVA component in solar simulated UV (SSUV).
Similar UV radiation is likely to be absorbed by humans during prolonged sunlight exposure
through a UVB-blocking topical sunscreen. Groups of mice were irradiated with SSUV or the
UVA-enhanced sources, with a dose providing a constant UVB component equal to the UVB of
3MED of SSUV. Erythema was measured by its oedema component as skinfold thickness,
immune function as contact hypersensitivity, and cutaneous cytokines were identified by
immunohistochemistry.
Results: We report that progressively increasing the UVA component of the radiation, while
maintaining a constant UVB dose, resulted in a reduction of both the erythema/oedema reaction,
and the degree of systemic immunosuppression. The UVA-enhanced immunoprotection was
abrogated in mice treated with a specific HO enzyme inhibitor. UVA-enhanced radiation also
upregulated the expression of cutaneous IFN-g and IL-12, and inhibited expression of both IL-6
and IL-10, compared with SSUV.
Conclusions: The results were consistent with the previously characterized mechanisms of
photoprotection by the UVA waveband alone, and suggest that the UVA component of solar UV
may have beneficial properties for humans.
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Genetic pathways to melanoma
A.V. Sklavos1, K. Byth Wilson1, E.A. Holland1, R.F. Kefford1, E.Gow2, G.J. Mann1
1University of Sydney at the Westmead Millennium Institute and 2Westmead Hospital
Department of Dermatology
Background: Cutaneous malignant melanoma (CMM) is a heterogeneous disease. Delineating the
molecular pathogenesis underlying its varying clinical presentations will assist with the further
understanding of the aetiology of this complex problem.
Methods: We have conducted genotype-phenotype studies on a cohort of 11 Australian CDKN2A
(p16INK4a/p14ARF) mutation positive (-34G4T, Ala36Pro, Ile49Ser, Met53Ile, Gly67Ser,
Asn71Ser) and 14 CDKN2A negative multiple-case CMM families (n¼143 subjects, both
affected and unaffected by CMM). First, we delineated associations between CMM and
susceptibility alleles (CDKN2A, MC1R), naevus and sun-sensitive phenotypes by conditional
logistic regression. Equations were modeled to adjust for CDKN2A and MC1R mutation status to
observe for variations in the strength of associations. We then explored, via factor analysis and
receiver operating curves, hierarchical cluster analysis and the construction of dendrograms, the
way in which these phenotypic and underlying genetic risk factors aggregated into distinct
clusters. We aimed in this way to determine what clinical heterogeneity existed in the cohort, and
how this might relate to degrees of CMM risk.
Results: Three clusters characterized by low, moderate and high risk of CMM were recognised. In
the low risk category 6.5% of subjects had CMM, 20% in the moderate and 76% in the high risk-
category. The high-risk candidates’ clustered characteristics included positive CDKN2A mutation
status and high counts of banal and clinically atypical naevi. The moderate risk group was
typically CDKN2A mutation negative, had fewer moles, had darker features of pigmentation, but
had greater evidence of sun-sensitivity indicating, perhaps, higher degrees of sun-exposure.
Variants of MC1R were shown to be associated with this sun-sensitive phenotype.
Conclusions: These data provide further evidence of the clinical heterogeneity of individuals
highly predisposed to CMM even in the presence of a strong family history. Further analysis is
required to determine if the ‘‘lower risk’’ sun-sensitive cluster is truly due to intrinsic, potentially
genetic, sun sensitivity or simply due to higher levels of sun exposure.
T cell shape and function is orchestrated by a network of T polarity proteins
Russell, SM, Ludford-Menting, MJ, Jane Oliaro, J, Sacirbegovic, F, Cheah, ETY, Pedersen, N,
Thomas, S, Pasam, A, Iazzolino, R, Dow, LE, Waterhouse, NE, Murphy, A, Ellis, S, Smyth, MJ,
Kershaw, MH, Darcy, PK, Humbert, PO Peter MacCallum Cancer Centre, East Melbourne, Vic,
Australia
T cell shape is dictated by the selective recruitment of molecules to polarized regions of the cell,
and is integral to every aspect of T cell function, from migration to cytotoxicity. We have recently
described a novel mechanism for the regulation of T cell polarity, coordinated by an asymmetric
network with the capacity to dictate the subcellular localization of cell surface receptors,
signaling and morphological determinants1. This polarity network includes proteins from the
Scribble, Crumbs3 and Par3 complexes, whose roles in coordinating intracellular signaling and
cytoskeletal reorganization are well understood in other cell types.
We describe here further analysis of the functional role of a number of polarity proteins in
regulating early and late responses to antigen presentation, and in orchestrating T cell
development and activation. Polarity proteins interact with key proteins downstream of TCR
signals, to dictate their localization and function both at the immunological synapse and at the
distal pole. These studies demonstrate that the polarity network impacts upon a multiple
important T cell signaling pathways, and plays a fundamental role in lymphocyte signaling.
References
(1) Ludford-Menting et al. (2005), Immunity 22, 737.
The polarity regulator scribble in epithelial migration and cancer
Lukas E. Dow1,2, Jeffrey S. Kauffman1, Jacinta Caddy3, Andrew S. Peterson4, Stephen M. Jane3,
Sarah M. Russell5,6,7, Patrick O. Humbert1,2,7
1Cell Cycle & Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne,
Australia; 2Department of Biochemistry & Molecular Biology, University of Melbourne, Parkville,
Australia; 3Rotary Bone Marrow Research Laboratories, Parkville, Australia; 4Department of
Molecular Biology, Genentech Inc., San Francisco, USA; 5Immune Signalling Laboratory, Peter
MacCallum Cancer Centre, Melbourne, Australia; 6Cell Biology Laboratory, Centre for
MicroPhotonics, Faculty of Engineering and Industrial Sciences, Swinburne University of
Technology, Hawthorn, Australia and 7Department of Pathology, University of Melbourne,
Parkville, Australia
Loss of polarity is one of the earliest hallmarks of epithelial neoplasia and leads to aberrant
communication between the epithelial cell and its microenvironment. Understanding how
deregulation of polarity occurs and how it may contribute to tumour formation is a new and
unexplored area of cancer research. Genetic screens in Drosophila have identified scribble, discs
large (dlg) and lethal giant larvae (lgl) as key epithelial polarity regulators with mutation in any of
these genes resulting in loss of polarity, overproliferation and multilayering of epithelial cells
leading to 3D-tumourous overgrowth, and in the presence of activated Ras, invasion and
metastasis. We have recently described the human homologue of Scribble and demonstrated
using complementation studies in Drosophila that expression of human Scribble can also regulate
polarity and proliferation. Evidence from cancer patients suggests that Scribble and Dlg could act
as a tumour suppressor in some epithelial cancers with, in many cases, low levels of Scribble or
Dlg correlating with increased tumour invasiveness and malignancy. We have undertaken a
detailed functional analysis of Scribble in mammalian epithelial cells and mice mutant for
Scribble and uncovered a critical role for Scribble in the regulation of epithelial polarity required
for directed migration during development and wound healing in vivo. In addition, we show that
impaired human Scribble can function together with activated Ras to lead to increased invasion
and tumourigenesis. Therefore, Scribble can act to promote or inhibit migration dependent on the
cellular context. We propose that Scribble and other polarity regulators may be key signalling
molecules involved in a new pathway regulating epithelial tumour progression in mammals.
CD4þ T regulatory cells that accumulate in the skin draining lymph nodes of UVB
irradiated mice are poised to regulate systemic immune responses
S. Gorman, J. W-Y. Tan, P. H. Hart
Telethon Institute for Child Health Research, University of WA, Perth
Background: Ultraviolet B (UVB) radiation (280–320 nm) is an important environmental factor
known to induce skin neoplasms as well as suppressing tumour-specific immune responses. The
mechanisms by which erythemal UVB irradiation modulates immune responses to antigens
applied to non-irradiated sites are poorly understood.
Methods: Naı¨ve OVA TCR congenic (DO11.10) or BALB/c mice were irradiated with UVB (8 kJ/
m2; three minimal erythemal doses). Four days after irradiation the proportion and activation
status of T cells from the skin draining lymph nodes (SDLN) were analysed by flow cytometry. The
capacity of CD4þ T cells isolated from SDLN of DO11.10 mice to proliferate and secrete
cytokines (IFNg, IL-10, IL-2) was measured by in vitro CFSE dilution and thymidine incorporation
assays. Real-time PCR and intracellular staining techniques were used to determine the
expression of the transcription factor FoxP3 in various T cell populations. Contact hypersensitivity
responses (CHS) to hapten were tested in BALB/c mice after the adoptive transfer of CD4þ T cells
purified from the SDLN of donor mice.
Results: The cellularity of the SDLN of DO11.10 mice was significantly increased by up to 50%
following irradiation with UVB. The profile of cells within the SDLN was altered with a significant
reduction of CD4þ T cells from 55 to 51% and significant increases of CD19þ B cells from 31 to
36% and CD8þ T cells from 6 to 7% (for n¼8 exp). Both whole SDLN and purified CD4þ T
cells from UVB-irradiated DO11.10 mice had diminished capacities to respond to presentation of
OVA peptide (OVA323-339) in vitro, with reduced IL-2 secretion. Within the SDLN and CD4
þ T
cell populations from the UVB irradiated mice there were significant increases in the proportions
of CD4þCD25þ cells by 10 (from 3.8 to 4.2%) and 22% (from 6.8 to 8.3%), respectively. Within
the CD4þ T cell population, there was a 38% increase in the proportion of Foxp3þ cells from
4.9 to 6.7% in control and UVB irradiated mice, respectively. Adoptive transfer of CD4þ T cells
from SDLN of UVB-irradiated BALB/c mice significantly suppressed CHS responses in recipient
mice.
Conclusion: Following UVB irradiation, there is an accumulation of CD4þFoxp3þ regulatory
cells in the SDLN that are poised to regulate responses to incoming antigens.
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Determination of an action spectrum for ultraviolet radiation-induced suppression
of cutaneous recall responses in humans
Yasmin J Renwick, Anil Kurien, Tai Phan, Gary M Halliday and Diona L Damian
Dermatology, Melanoma and Skin Cancer Research Institute, Sydney Cancer Centre, University
of Sydney at Royal Prince Alfred Hospital, Camperdown, 2050, Australia
Objective: Ultraviolet (UV) radiation in sunlight contributes to skin cancer development through
multiple mechanisms, including DNA damage and also suppression of cutaneous immune
responses. The relative roles of UVB (290–320 nm) and UVA (320–400 nm) in skin immunity and
carcinogenesis are unknown. Our aim was to determine the precise wavelengths responsible for
UV radiation-induced immunosuppression in humans.
Materials/Methods: We recruited groups of healthy, nickel-allergic volunteers and exposed
discrete areas on their lower backs to graded doses of solar-simulated (ss) or narrowband UV
centred at various UVB and UVA wavelengths. This was performed using an Oriel (Stratford, CT)
Solar Simulator. Adjacent unirradiated areas of skin served as immunologically intact control
sites. After UV exposure, nickel patches were placed on each of the irradiated and unirradiated
test sites. The intensity of nickel CHS responses at each site was measured with a reflectance
erythema meter as nickel-induced erythema (NIE) 72 hours later. The degree of immunosuppres-
sion caused by exposure to each UV waveband and dose was then calculated by comparing the
NIE of irradiated test sites with that of unirradiated control sites.
Results: We found significant, dose-responsive immunosuppression with irradiation centred at
290, 300, and 310 nm. Significant degrees of immunosuppression occurred with irradiation at the
370 nm wavelength, with a bell shaped dose-response relationship.
Conclusions: Peaks in immunosuppression were observed not only in the UVB spectrum, but also
in the long-wavelength UVA. Our results emphasise the importance of protection against UVA as
well as UVB, and have implications for sunscreen design. The 370 nm waveband probably causes
more immunosuppression than the UVB wavebands in real life, due to its relative abundance in
solar radiation.
Supported by: National Health and Medical Research Council of Australia
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The role of NF-jB in UV-induced signalling in mouse keratinocytes
Kasey S-K. CHAN1, Raffi Gugasyan2, Tien Huynh1 and Terrence J. Piva1
1School of Medical Science, RMIT University, Bundoora,Victoria and 2Walter and Eliza Hall
Institute, Parkville, Victoria
Background: Abnormalities in the epidermis that occur as a result of prolonged UV exposure can
result in immune-mediated inflammatory skin disease or skin cancer. A key intracellular
signalling pathway involved in skin development and function is the Rel/NF-kB pathway. NF-kB
activates a range of genes that are involved in cell survival, proliferation, differentiation and
apoptosis.
Method: Cultures of HaCaT, Colo16 and primary mouse (both adult and embryonic)
keratinocytes were exposed to UVA, UVB or UVC radiation. Cell viability was determined 24
and 48 hours post-irradiation using either trypan blue (HaCaT and Colo16 cells) or propidium
iodide (primary mouse keratinocytes). Time-course of UV-induced NF-kB activation in HaCaT
cells was determined using Western blots probed with the phospho-IkB-a (Ser-32) antibody.
Results: UVA at high doses (40 000 Jm2) was not toxic in any cell line examined. Colo16 cells
were the most susceptible cell line to UVB radiation compared to the other cell types examined.
All the cell types were highly sensitive to UVC radiation. The viability of c-Rel, NF-kB1 or NF-kB2
deficient keratinocytes following UV radiation was similar to that seen in wild type controls. A
high level of phospho-IkB-a (Ser-32) was found at 0 hours post UV-irradiation in HaCaT cells,
which gradually decreased over time following exposure to UV radiation.
Conclusion: The high level of constitutive NF-kB activity observed in HaCaT cells suggests that
caution should be taken when using these cells to study the NF-kB pathway. c-Rel, NF-kB1 or NF-
kB2 are not involved in cell survival response upon UV stimulation, however the role Rel B and
Rel A plays in this process requires further investigation.
The effect of UV radiation on the expression of furin and p38 in human
keratinocyte cell lines
Tien T. HUYNH, Kasey S-K. Chan and Terrence J. Piva
School of Medical Science, RMIT University, Bundoora, Victoria
Background: UV radiation is known to cause a number of events in the skin such as DNA
damage, tumour formation, formation of sunburnt keratinocytes, as well as the induction of local
and systemic immunosuppression. Cytokines such as TNFa, are, in part, responsible for these
latter responses. In order for TNFa to be released from the cell, it must first be cleaved by TACE,
which in turn is processed by furin, a proprotein convertase. UV radiation stimulates the p38
MAPK signalling pathway, but is unknown if this pathway is involved in furin activation.
Method: Cultures of the human keratinocyte cell lines, HaCaT and Colo16 cells were irradiated
with UVA and/or UVB radiation and changes in the expression of p38 and furin protein levels
were measured over a 48 hours period. Cell viability was measured using trypan blue exclusion.
Results: HaCaT cells were more sensitive to UVA radiation compared to Colo16 cells, while the
reverse was seen when the cells were irradiated with either UVB or UVA plus UVB. The level of
p38 expressed in HaCaT cells fell following exposure to UV radiation, while in Colo16 cells the
levels remained constant and increased up to 10-fold in cells irradiated with a high UVA dose.
Furin levels fell in UV-irradiated HaCaT cells following exposure while in Colo16 cells remained
constant and increased in cells exposed to high doses of UVB and UVA plus B radiation.
Conclusion: These findings demonstrate that the malignant transformation of keratinocytes results
in a upregulation of intracellular processes which respond differently to UV radiation than that
observed in non tumorous cells.
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Modelling cellular heterogeneity in cancer: therapeutic implications
Stephen Gilmore, MD FACD Department of Dermatology, St Vincent’s Hospital, Melbourne,
Australia & Mathematical Institute, University of Oxford, United Kingdom
The development of human cancer is a multi-step process occurring over decades. Although most
tumours retain features that allow classification according to their tissue of origin, a biological
hierarchy of heterogeneity exists between tumours of the same origin and between cells within
individual tumours. Aneuploidy, chromosomal aberrations, deletions, insertions and point
mutations are frequent and surprisingly heterogeneous, even within individual tumours. It has
been estimated that the average human cancer cell may harbor up to 100 000 mutations1.
Consequently, not only is each tumour unique, but individual or small groups of malignant cells
within a single tumour are likely to manifest a unique genetic signature. An attractive hypothesis
to account for such cellular heterogeneity is the idea that malignant cells bear a mutator
phenotype1. In this case, the high mutation rates of cancerous cells are due to mutations affecting
genes involved in protecting genomic fidelity such as those regulating chromosomal segregation,
DNA synthesis, or DNA repair. Since there is a wide range of genotypes that can potentially adapt
to changing environmental conditions (eg. increased acidity, hypoxia, host responses etc), genetic
instability promotes cancer progression via a Darwinian-like selection process. Coupled to this
Darwinian or clonal selection, the mutator phenotype can drive the progression of cancer from
metaplasia to dysplasia to frank malignancy. Yet if the mutation rate is too high deleterious effects
on proliferative potential may ensue. Hence there may be selection against further increases to
mutation rates in advanced malignancies.
Here I investigate the trade-off between mutation rate and the proliferative and adaptive potential
of cancer cell populations with a bit-string computer model of genomic evolution. I show how the
model reproduces many of the features of molecular evolution, including progression toward a
quasi-species distribution of mutationally coupled genotypes via punctuated-equilibria fitness
gains. Although the model is able to demonstrate an error catastrophe with marginally increased
mutation rates, here I show that a mutational meltdown is required in order to severely decrease
the average fitness of the population.
References
(1) Loeb LA. Cancer Research 61, 3230-9, 2001.
Marigold therapy and homeopathy in the treatment of viral warts at the royal
London hospital
Dr M Tariq Khan1, Prof Rino Cerio2, Dr M Taufiq Khan3
1Consultant Podiatrist and Specialist in Homeopathic Podiatry, Deputy Director Marigold Clinic,
Department of Homeopathic Podiatry, The Royal London Homeopathic Hospital UCLH NHS
Foundation Trust. Honorary Research Fellow in Dermatology, Barts and The Royal London
Hospitals NHS Trust; 2Consultant Dermatologist, Barts and The Royal London Hospitals NHS
Trust and 3Honorary Director of Homeopathic Podiatry Services, The Royal London
Homeopathic Hospital UCLH NHS Foundation Trust
Since 1997 the complementary wart clinic has been established in the Department of
Dermatology. Clinical trials have been carried out (Khan1,2) as well as an audit, to evaluate the
effectiveness of Marigold therapy and Homeopathy on patients seen in this clinic.
The total number of patients seen during the period was 186, the number of patients that were
discharged following resolution of their condition, 123. The percentage rate of discharge for the
clinic was 81%, in comparison to general wart clinics where the discharge rate due to resolution
is 30-40%. The types of warts seen in the clinic, showed 88 common warts, 48 mosaic, 14
plantar, 7 plane/flat and 10 filiform. 18 presented with a combination of common and mosaic and
1 presented with verruca vulgaris. The duration of warts present, prior to attending the clinic was
noted, and divided up into three groups. 42 patients had suffered o2 years, 103 patients 2-5
years, and 41 patients 45 years. These points of duration were important, as the normal
regression rate and spontaneous resolution time frame is 2 years. Any lesion deemed to be
recalcitrant, is normally present after this time frame. Final part of the audit addressed the types of
treatments patients had prior to attending the clinic. The results were most interesting, in that 99
patients had used-over-the counter preparations, 21 had cryotherapy, 2 patients had not received
any previous treatment, 1 patient had electrodessication and 1 patient had everything!
We can conclude from this, that not only is this form of treatment most effective, but it is superior
to other more conventional alternatives, whilst offering a non-invasive painless treatment to a
wide spectrum of patients of all age groups, and contraindicated to other treatments rationale.
References
(1) Khan MT, Cerio R, Watt R, Khan MT snr (1999) A double blind placebo study of Thuja
occidentalis on verruca pedis in children and adults. Journal of the European Academy of
Dermatology and Venereology. 1: S251.
(2) Khan MT, Cerio R, Khan MT snr (1998) The efficacy of Thuja occidentalis on verruca pedis in
children and adults. Journal of the European Academy of Dermatology and Venereology. 11:
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Randomised controlled trial of minigrafting versus recell in stable vitiligo
Linda Martin1, Richard Wittal2, De´de´e F Murrell1,3, John Le Guay2
1Department of Dermatology, St George Hospital, Sydney and 2Vitiligo Clinic, Skin and Cancer
Foundation, Darlinghurst and 3University of New South Wales, Sydney
Background: Although vitiligo is a common condition with significant morbidity, its pathogenesis
is poorly understood and treatment is generally unsatisfactory. The ultimate aim of management is
restoration of normal skin colour, and while a number of medical and surgical approaches for
repigmentation have been described, the efficacy and safety of these have been poorly studied.
Autologous melanocyte transplantation is indicated in chronic stable vitiligo which is refractory to
medical management. Techniques available include skin grafts (split-thickness skin grafts, mini-
grafts, epidermal blister grafts, and follicular grafts) and cellular suspensions (non-cultured
epidermal suspensions, cultured epidermal suspensions and purified cultured melanocyte
suspensions).
Objective: This study was designed to evaluate and compare the efficacy and safety of mini-
grafting and non-cultured epidermal suspension as surgical repigmentation techniques for chronic
stable vitiligo.
Methodology: This is a prospective intra-patient randomised controlled trial. Mini-grafting and
non-cultured epidermal suspension are performed on each patient on anatomically matched sites.
Mini-grafting involves transplantation of multiple miniature full thickness punch grafts. Non-
cultured epidermal suspension will be performed using the ReCell Kit – a novel cell harvesting
device originally developed for the treatment of burns. Before invasive procedures a pilot
minigraft is performed as an objective measure of disease stability. Outcome measures include
percentage repigmentation at 6 months and patient assessment of cosmetic outcome.
Conclusion: Restoration of normal pigmentation is the ultimate goal of vitiligo research and
management, and mini-grafting and non-cultured epidermal suspension show promising clinical
utility. Moreover these techniques are relatively simple and could feasibly be incorporated into
routine clinical practice in an outpatient setting.
The effect of UV radiation on furin and tace activity in hacat cells
Terrence J. PIVA, Bronwyn Neill and Beata Skiba School of Medical Science, RMIT University,
Plenty Road, Bundoora, Victoria
Background: Following exposure to UV-irradiation skin cells such as keratinocytes and
melanocytes have been shown to secrete TNFa [1]. Soluble TNFa is secreted from its
membrane-bound precursor by the action of the metalloprotease TACE. However for TACE to
be activated it must be cleaved from its precursor by the action of the proprotein convertase furin
[2]. It is unknown what effect UV radiation has on furin activity and its role in activating TACE in
keratinocytes.
Method: Cultures of the human keratincocyte cell line, HaCaT cells were exposed to both UVA
and UVB radiation and furin and TACE mRNA and protein levels were measured over a 24 hours
period. TNFa levels in the culture media were measured using ELISA kits. Cell viability was
determined using trypan blue exclusion.
Results: Following viability studies HaCaT cell cultures were exposed to either UVA (2000 and
20000 Jm2) or UVB (200 and 2000 Jm2) radiation. Cultures exposed to higher doses of UVA
and UVB resulted in increased secretion of TNFa compared to controls or those exposed to lower
UV doses. There was a correlation between mRNA and protein expression for TACE in irradiated
cells, with reduced levels of both seen at high UV doses. However this differed for furin, where
there were increased protein and reduced mRNA expression at high UV doses.
Conclusion: These studies suggest that UV radiation has a minimal effect on TACE and furin
expression at a cellular and molecular level and that the increased TNFa released by HaCaT cells
may be due to other mechanisms such as elevated TACE activity.
References
(1) Barr RM, et al., (1999) J Invest Dermatol. 112: 692-698
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Novel mutations in the ITGB4 gene associated with a mild phenotype in
junctional epidermolysis bullosa with pyloric atresia: two siblings with differential
expression of pyloric atresia
Adam I. Rubin1, Ningning Dang1, Matthew Edwards2, Siegfried Borelli3, John Relic4, Jouni Uitto5,
Dedee F. Murrell1,6
1Dept of Dermatology, St George Hospital, Sydney; 2Hunter Genetics & University of Newcastle,
NSW; 3Triemli Hospital, Zurich, Switzerland; 4John Hunter Hospital, Newcastle, Australia; 5Dept
of Dermatology, Thomas Jefferson University, Philadelphia, PA and 6University of NSW, Sydney
Background: Junctional Epidermolysis Bullosa with pyloric atresia (JEB-PA) is caused by
mutations in either the ITGA6 or ITGB4 genes. It is unusual to encounter patients with JEB-PA
with a mild phenotype and unique to have two patients with the same mutation only one of
whom had pyloric stenosis.
Method: The two siblings were investigated by immunofluorescence mapping, electron
microscopy and molecular genetic analysis. A review of known mutations of both the alpha 6
and beta 4 integrin genes and the phenotypes of the patients with JEB-PA was undertaken.
Results: The siblings had only mild skin involvement with blistering on the feet in summertime
and no abnormal internal manifestations other than pyloric atresia in the younger of the two. IFM
showed very reduced staining for both integrins A6 and B4. Both children were homozygous for
two novel mutations in the ITB4 gene. The paternal mutation is 264g-4a at the exon 4 intron 4
splice junction and is predicted to cause mis-splicing. The maternal mutation is a 3111-1g-4a
splice junction mutation, and is also predicted to cause mis-splicing by altering the splice
sequence at the border of intron 26 and exon 27. One explanation for the mild phenotype is that
possibly a small amount of RNA undergoes normal splicing, producing a small amount of
functional ITB4 protein product. A map of known mutations in the alpha 6 and beta 4 integrin
genes is presented. The mutations presented here have not been previously identified, and result
in an unusual variant of JEB-PA with a mild phenotype.
Conclusion: We present two siblings with an unusually mild variant of JEB-PA associated with
novel mutations in the ITB4 gene. Why one sibling did not present with pyloric atresia despite the
identical mutations suggests that alternative splicing or other mechanisms may overcome the
effect of these mutations. A review of known mutations in the ITB4 gene is also presented.
Induction of MMP-1 and MMP-3 in normal dermal fibroblasts by chronic venous
leg ulcer wound fluid
K. Subramaniam1, C. Pech1, H. Wallace1, MC Stacey1
1School of Surgery & Pathology, University of Western Australia, Fremantle Hospital, WA
Background: Elevated levels of matrix metalloproteinase-1, -3 (MMP-1, -3) in venous leg ulcer
wound fluid may be due to production by ulcer fibroblasts. Both MMP-1 and MMP-3 are found in
fibroblasts underlying non-healing ulcer epithelium. The aim of this study was to determine if
wound fluid from chronic venous ulcers contains factors capable of inducing production of MMP-
1, –3 and also a regulator of MMP activation and activity, tissue inhibitor of metalloproteinase-1
(TIMP-1), by dermal fibroblasts.
Method: Chronic wound fluid was collected from 9 patients with chronic non-healing venous leg
ulcers. Acute wound fluid from drains of 8 patients who underwent mastectomy was collected on
day 3 post-surgery. Acute wound fluid was also collected from the upper thigh graft donor sites of
3 patients undergoing skin grafting on day 3 post-graft. Normal human neonatal dermal
fibroblasts were incubated for 24 hours with pooled 5% chronic wound fluid, pooled 5% acute
mastectomy wound fluid or pooled 5% acute graft wound fluid, with 10% fetal bovine serum.
Total MMP-1, MMP-3 and TIMP-1 in test media and culture supernatants from 2 experiments
were measured by ELISA. Concentrations were normalised to the number of adherent fibroblasts.
Results: The mean normalised concentration of MMP-1 induced by chronic wound fluid was
significantly higher (90.5 ng/ml; P¼ 0.004) than the concentration induced by acute mastectomy
wound fluid or acute graft wound fluid (15.3 ng/ml and 32.7 ng/ml respectively). Chronic wound
fluid also induced significantly more MMP-3 secretion (mean 350 ng/ml; P¼0.002) compared to
acute mastectomy wound fluid or acute graft wound fluid (mean 42.1 ng/ml and 177.4 ng/ml
respectively). TIMP-1 secretion was similar with all types of wound fluid.
Conclusion: Venous ulcer wound fluid induced greater production of MMP-1 and MMP-3 by
dermal fibroblasts than acute wound fluid, but this was not matched by an increase in TIMP-1.
Inducers of MMP expression include IL-1 and TNF-alpha (TNF-a), which are present at higher
levels in ulcer wound fluid than in acute wound fluid. If further work shows that IL-1 or TNF-a are
responsible for inducing MMP-1 and -3 in ulcer fibroblasts, treatments aimed at reducing these
pro-inflammatory mediators may also reduce matrix degradation.
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